Why we are here.
At RedGen, we are committed to revolutionizing health and wellness through cutting-edge red light therapy technology. Our mission is to deliver scientifically-backed, innovative solutions that empower individuals and businesses to enhance vitality, reduce stress, and promote overall well-being. We strive to make this advanced technology accessible to clinics, spas, hotels, and fitness centers worldwide, ensuring quality, safety, and effectiveness in every product we offer.
Mission Statement
Vision Statement
Our vision is to become the global leader in red light therapy solutions, pioneering advancements in natural health technologies. We aim to improve lives by promoting accessible, non-invasive therapies that combat stress, inflammation, and chronic health issues, ultimately contributing to a healthier, more vibrant world.
The RedGen team is dedicated to revolutionizing red light therapy. With over 30 years of experience in manufacturing, design, and distribution, our team have sold thousands of machines worldwide. Our expertise spans medical, scientific, regulatory affairs, franchising, and manufacturing, ensuring the highest standards of quality and reliability. Committed to innovation and wellness, we are driving forward cutting-edge solutions to enhance health and well-being globally. Discover the experts shaping the future of red light therapy.
Meet Our Team
David Leoncavallo
Chief Executive Officer
David Leoncavallo is leading the company’s mission to bring cutting-edge red light therapy technology to a global market. With over 30 years of experience in franchising, private equity, and human capital, David has been a driving force behind the success of numerous wellness and franchise brands. His expertise in AI & technology has played a key role in developing RedGen’s innovative solutions. As a seasoned entrepreneur, David has helped franchisors grow to thousands of locations, and now, through RedGen, he is expanding the reach of advanced wellness technology to promote health and well-being worldwide.
Myleen Leoncavallo
Chief Scientific Officer
Myleen Leoncavallo is an accomplished scientific executive with over 26 years of experience in the pharmaceutical industry, specializing in regulatory affairs and drug development. She has been instrumental in obtaining global approvals for rare disease medications, working closely with agencies like the FDA and EMA. As Chief Scientific Officer of RedGen, Myleen leverages her extensive expertise to oversee the development and distribution of advanced red light therapy technology worldwide. Her passion for natural health alternatives drives her to ensure that RedGen’s products meet the highest standards of safety and efficacy, providing accessible wellness solutions globally.